Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
9.46
+0.11 (1.18%)
At close: Aug 25, 2025, 4:00 PM
9.01
-0.45 (-4.76%)
After-hours: Aug 25, 2025, 7:10 PM EDT

Artelo Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20212016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Aug '21 2016 - 2020
133482222
Upgrade
Market Cap Growth
109.79%-23.37%-45.90%-62.41%-1.60%416.89%
Upgrade
Enterprise Value
10-1-8-111212
Upgrade
Last Close Price
9.356.368.4017.3446.7181.98
Upgrade
PB Ratio
-1.200.380.430.811.85
Upgrade
P/TBV Ratio
-4.180.460.480.872.23
Upgrade
Debt / Equity Ratio
-0.620.040.000.000.000.01
Upgrade
Quick Ratio
0.361.328.0817.5723.4819.14
Upgrade
Current Ratio
0.391.448.5118.3623.9619.61
Upgrade
Return on Equity (ROE)
-356.46%-134.52%-59.63%-43.30%--93.45%
Upgrade
Return on Assets (ROA)
-103.84%-71.22%-37.09%-26.42%--54.68%
Upgrade
Return on Capital (ROIC)
-191.12%-85.74%-39.73%-27.52%--58.09%
Upgrade
Earnings Yield
-91.35%-287.20%-208.06%-122.17%-55.14%-33.33%
Upgrade
FCF Yield
-47.45%-244.06%-183.83%-97.03%-36.44%-27.52%
Upgrade
Buyback Yield / Dilution
-5.99%-8.88%-4.48%-27.04%-79.12%-403.69%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q